Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Lichtblau (Zürich, Switzerland), M. Furian (Zürich, Switzerland), L. Meyer (Zürich, Switzerland), A. Buergin (Zürich, Switzerland), P. Scheiwiller (Zürich, Switzerland), S. Saxer (Zürich, Switzerland), U. Sheraliev (Bishkek, Kyrgyzstan), M. Mademilov (Bishkek, Kyrgyzstan), P. Bader (Zürich, Switzerland), S. Schneider (Zürich, Switzerland), F. Tanner (Zürich, Switzerland), T. Sooronbaev (Bishkek, Kyrgyzstan), K. Bloch (Zürich, Switzerland), S. Ulrich (Zürich, Switzerland). Effect of acetazolamide on pulmonary hemodynamics in COPD-patients going to altitude: a randomized trial. 1450

Member's Comments

No comment yet.

Related content which might interest you: Acute hemodynamic effect of acetazolamide in patients with pulmonary hypertension whilst breathing normoxic and hypoxic air: a randomized cross-over trial Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Effect of a day-trip to altitude (2500 m) on exercise performance in pulmonary hypertension: randomised crossover trial Source: ERJ Open Res, 7 (4) 00314-2021; 10.1183/23120541.00314-2021 Year: 2021 Effect of high-flow oxygen therapy on exercise tolerance in idiopathic pulmonary fibrosis: a randomized crossover trial. Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2021 Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Effects of Rho-kinase inhibitor fasudil on pulmonary arterial pressure in highlanders with high altitude pulmonary hypertension. (Double-blind placebo-controlled study) Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Dexamethasone reduces pulmonary artery pressure in lowlanders with COPD travelling to 3200m. A randomized, placebo-controlled trial Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Effects of downhill walking in pulmonary rehabilitation for patients with COPD: a randomised controlled trial Source: Eur Respir J, 56 (3) 2000639; 10.1183/13993003.00639-2020 Year: 2020 Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2016 Effects of intermittent exposure to high altitude (HA) on pulmonary haemodynamics: a prospective study Source: Eur Respir J 2003; 22: Suppl. 45, 268s Year: 2003 Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN) Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Maintenance of exercise capacity following pulmonary rehabilitation in COPD: randomised controlled trial Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions Year: 2009 Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Domiciliary high-flow nasal cannula oxygen therapy for stable hypercapnic chronic obstructive pulmonary disease: a prospective, multicentre, randomised crossover trial Source: International Congress 2017 – New insights in chronic respiratory failure Year: 2017 Effect of nocturnal oxygen therapy on daytime pulmonary hemodynamics in patients with COPD travelling to altitude. RCT. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Effects of phosphodiesterase type 5 inhibitor on pulmonary hemodynamics in the patients with high altitude pulmonary hypertension (results of 12 week randomized, blind, placebo-controlled study) Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005 Late Breaking Abstract - Effect of oxygen supplementation on sleep and nocturnal breathing in patients with chronic obstructive pulmonary disease travelling to high altitude: randomized trial Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018 Effectiveness and safety of hypertonic saline inhalation combined with exercise training in patients with chronic obstructive pulmonary disease: a randomized trial Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions Year: 2009 Effect of breathing oxygen-enriched air on exercise performance in patients with pulmonary hypertension in heart failure with preserved ejection fraction. Randomized, placebo-controlled, cross-over trial. Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension Year: 2021